Page 68 - SaxoCell Annual Report22/23

Outlook

To the end of the 1st and the beginning of the 2nd funding phase

The first funding phase of SaxoCell covers the period from October 2021 to the end of
September 2024. In the first part of this first phase, almost all projects were able to start as
planned and generate the first important results in collaboration with their cluster partners.
Framework programs around the research activities, such as continuing education events,
marketing and transfer events, and networking meetings with other German clusters of
similar, thematic focus, have also been established.

The upcoming second half of the first funding period is now fully dedicated to the successful
completion of the projects and the achievement of the set milestones as well as, of course,
the preparation of the new funding period. In order to complete the projects as planned, they
will be surveyed by the Hub team on a quarterly basis and support will be offered or arranged
as needed. The Scientific Advisory Board also supports the projects and platforms in an
advisory capacity. The founding of SaxoCell e.V. following this year's 2023 consortium
meeting will also enable us to involve interested companies and stakeholders in the cluster in
the future, even during the course of the funding period.

In addition, the Hub is planning numerous events in which SaxoCell members will participate,
such as Bio-Europe 2023 in Munich and the Leipzig Immunoncology Conference (LION).
Networking meetings with other collaborative projects, such as BioRN, the science and
industry cluster around Heidelberg, and ProxiDrugs, the future cluster from Frankfurt, are also
scheduled for late 2023. A Parliamentary Evening will also be organized for networking and as
a discussion platform between SaxoCell PIs and members from politics and regulation. In
addition to numerous specially organized workshops, including on Good Scientific Practice
(GSP), we will present two joint sessions at the annual meeting of the Interdisciplinary Group
for Flow Cytometry and Laboratory Medicine IGDL in Leipzig in March 2024, where SaxoCell
will present itself to a national audience.

63